Check out this morning's top movers from around Wall Street, compiled by The Fly. 

HIGHER -  

• Uber (UBER) up 9% after announcing an agreement to acquire Postmates for approximately $2.65B in an all-stock transaction
• Regeneron (REGN) up 3% after announcing the initiation of late-stage clinical trials evaluating REGN-COV2, the company's investigational double antibody cocktail for the treatment and prevention of COVID-19
• Becton Dickinson (BDX) up 4% after announcing that the FDA granted Emergency Use Authorization, or EUA, for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its "broadly available" BD Veritor Plus System
• Sally Beauty (SBH) up 12% after reporting preliminary Q2 revenue above consensus and providing a business update amid COVID-19
• U.S. Silica (SLCA) up 3% after Evercore ISI analyst Samantha Hoh upgraded shares to In Line from Underperform with a $3 price target.

LOWER -

• Spotify (SPOT) down 1% after Bernstein analyst Todd Juenger downgraded the stock to Underperform from Market Perform with a price target of $172, up from $134
• Precision Biosciences (DTIL) down 6% after reporting that the company will regain full rights and all data it generated for the in vivo chronic hepatitis B virus program developed under its 2018 collaboration agreement with Gilead (GILD)
• Dominion (D) down 2% after Berkshire Hathaway Energy, a subsidiary of Berkshire Hathaway (BRK.A), announced it has executed a definitive agreement to acquire the company's natural gas transmission and storage business
• ObsEva (OBSV) down 33% after announcing top-line results from the PRIMROSE 1 and 2 studies of Yselty to assess the efficacy and safety in women with heavy menstrual bleeding due to uterine fibroids